SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius has been swept into a neocloud and AI-infrastructure selloff amid concerns about CoreWeaves debt, Gartners warning about the sectors long-term viability, and hotter inflation weighing on technology shares. Traders are debating whether the drop is an overreactionsome argue Nebius is better financed than peers and bought the rebound, while others see broader AI investment and funding risks.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULFs sharp rebound after a steep selloff is being linked by traders to CEO Paul Pragers CNBC defense of the companys AI data-center model and Morgan Stanleys view that the shares are mispriced. Bulls see a possible capitulation reversal, while skeptics call it a relief bounce and point to ongoing sector concerns about financing, leverage, and rates.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a sharp neocloud selloff as concerns about CoreWeaves debt and bond yields, Gartners warning about AI infrastructure providers, and tighter financing conditions weigh on the sector. Traders are split between fearing an AI-infrastructure downturn and viewing IRENs comparatively stronger balance sheet and customer contracts as a reason to buy the dip.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns over CoreWeaves debt and rising bond yields, alongside broader doubts about AI infrastructure spending, fueled a sharp selloff before Nvidia CEO Jensen Huangs confidence in the companys improving finances helped spark a strong rebound. Traders celebrated the reversal and bought the dip, while skeptics continued to question whether CoreWeave can fund its growth and service its debt.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows AI-agent governance push, including its AI Passport launch with NVIDIA as the first partner, is drawing attention alongside a broader rotation from chip stocks into software. Traders are cheering the sharp rebound and testing of resistance, while some question whether the gains can hold.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor-sector selloff, fueled by hotter inflation data and concerns about AI valuations and chip competition, has driven attention to SOXL, whose 3 leverage magnifies the swings. Traders are split between viewing the decline as an oversold dip-buying opportunity and expecting further losses as rate and AI-spending worries persist.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs Neutron debut was pushed to 2027 after manufacturing defects were found in a carbon-composite tank component, prompting a sharp selloff. Traders are split between viewing the delay as a prudent safety decision and seeing another schedule slip as a sign of execution risk that could defer growth and profitability.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops rally to a new 52-week high and reported insider buying by CEO Ryan Cohen are driving attention, with bullish traders framing the purchases as a vote of confidence. The community is also speculating about a possible filing or eBay-related deal and debating warrant-expiry and short-squeeze scenarios, while some are cautious after the pullback.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

RGCs sharp move has revived speculation that the stock could repeat its past meme-stock spikes, with traders pointing to the tightly held float and alleged difficulty borrowing shares as potential squeeze dynamics. Others call the move a pump-and-dump and question the companys fundamentals, noting the conversation is largely momentum-driven rather than tied to a clear new catalyst.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASSs COMP360 is drawing attention after discussion of long-term Phase 3 follow-up data and expectations that its rolling FDA application for treatment-resistant depression could be completed soon, setting up a closely watched regulatory milestone. Traders are largely optimistic about the potential path to approval and commercialization, though some remain cautious about the timeline and the stocks volatile price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DataMeds AI, Inc. (Nasdaq: $MEDS ) launched its new corporate website, www.DataMedsAI.com, on September 21, 2026, with the redesigned site aligned to marketing initiatives now pending after two recently announced transactions. The launch follows the company&#39;s acquisition of Helomics Corporation&#39;s artificial intelligence cancer diagnostics lab from Axe Compute and the settlement of outstanding litigation tied to its 2023 acquisition of Wellgistics, LLC. 
 
DataMeds AI, Inc. is a B2i Digital Featured Company. See the company&#39;s in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 
 
Both the Helomics closing and the litigation settlement preceded the launch, and Gerald E. Commissiong ties them to the planned Health Lives Here consumer application: 
 
• DataMeds acquired Helomics Corporation&#39;s artificial intelligence cancer diagnostics lab, a CLIA-certified laboratory, from Axe Compute 
 
• The litigation settlement extinguished approximately $19 million in liabilities from the company&#39;s balance sheet and retired 364,099 common shares 
 
• Interim Co-CEO Gerald E. Commissiong said the Helomics closing and the litigation settlement leave the company ready to launch the Health Lives Here consumer application as it begins telling the DataMeds story to the broader market 
 
Regarding the new site, Gerald E. Commissiong, Interim Co-CEO of DataMeds, stated: &quot;Our new corporate website represents the parent company&#39;s new branding. We have retooled our marketing efforts to be AI-centric so that we are able to get organic traction online as we begin to draw earned media interest in our story. We intend to soft launch the Health Lives Here app in short order.&quot; 
 
Read the full release: https://datamedsai.com/datameds-ai-unveils-new-corporate-website/ 
 
DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy and pharmacy services, including the distribution of products developed by Tollo Health, LLC. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. 
 
B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. 
 
$OPRX, $HCAT, $PHR, $XLV

David Shapiro

fariha jabeen

Cody Mundorff

JP Mark

Den Tongco

Kier Golino

GMoney

Chris cottrell

Linda Scott

Bonnie Siegmund

Ariana Storck

Michael Musto

Craig Salinas

Eugene Davenport

Henry Callaghan

Roberta Creech

John Park

Shirley Hall

Micheal Fikes

Melissa Vermillion

Jeanne Hodges

James Adair

Kelly Distaffen

Renee Blankenship

Nina Studdard

Raymond Oliver

Filomena Marsh

Lucy Pena

Terry Skora

Amber Reilly

DataMEDS AI is building a connected healthcare ecosystem that brings together technology, data and specialized healthcare companies to make care more accessible, efficient and connected. Our portfolio spans pharmacy, telemedicine, laboratory services, health technology, distribution, wellness and patient support.

DataMeds AI

Home - DataMeds AI

DataMeds AI, Inc. (Nasdaq: MEDS) a Featured Profile on B2i Digital

B2idigital

DataMeds AI, Inc. | Nasdaq: MEDS | B2i Digital Featured Company

Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026 / DataMEDS AI, Inc. (NASDAQ:MEDS) (the "Company" or "DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it launched its new corporate website [...]

DataMEDS AI Unveils New Corporate Website - DataMeds AI

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2i Digital - Connecting companies and investors

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult an advisor before making any investments

StockTwits Web

DataMEDS AI Inc.

OptimizeRx Corp

Health Catalyst Inc

Phreesia Inc

Health Care Select Sector SPDR Fund

, on September 21, 2026, with the redesigned site aligned to marketing initiatives now pending after two recently announced transactions. The launch follows the company's acquisition of Helomics Corporation's artificial intelligence cancer diagnostics lab from Axe Compute and the settlement of outstanding litigation tied to its 2023 acquisition of Wellgistics, LLC. 
 
DataMeds AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: 

 
 
Both the Helomics closing and the litigation settlement preceded the launch, and Gerald E. Commissiong ties them to the planned Health Lives Here consumer application: 
 
• DataMeds acquired Helomics Corporation's artificial intelligence cancer diagnostics lab, a CLIA-certified laboratory, from Axe Compute 
 
• The litigation settlement extinguished approximately $19 million in liabilities from the company's balance sheet and retired 364,099 common shares 
 
• Interim Co-CEO Gerald E. Commissiong said the Helomics closing and the litigation settlement leave the company ready to launch the Health Lives Here consumer application as it begins telling the DataMeds story to the broader market 
 
Regarding the new site, Gerald E. Commissiong, Interim Co-CEO of DataMeds, stated: "Our new corporate website represents the parent company's new branding. We have retooled our marketing efforts to be AI-centric so that we are able to get organic traction online as we begin to draw earned media interest in our story. We intend to soft launch the Health Lives Here app in short order." 
 
Read the full release: 

 
 
DataMeds AI, Inc. (Nasdaq: MEDS) (formerly Wellgistics Health, Inc.) is a Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy and pharmacy services, including the distribution of products developed by Tollo Health, LLC. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at 

. 
 
B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://

DataMeds AI is advancing its Health IT strategy with a new AI-focused corporate website, following the Helomics acquisition and litigation settlement. The planned Health Lives Here app adds another interesting dimension to the company’s evolving platform. 
 
See DataMeds AI’s in-depth B2i Digital Featured Company profile at: https://b2idigital.com/datameds-ai-inc-1

DataMeds AI is advancing its Health IT strategy with a new AI-focused corporate website, following the Helomics acquisition and litigation settlement. The planned Health Lives Here app adds another interesting dimension to the company’s evolving platform. 
 
See DataMeds AI’s in-depth B2i Digital Featured Company profile at: 